Exact Mass: 396.1748
Exact Mass Matches: 396.1748
Found 325 metabolites which its exact mass value is equals to given mass value 396.1748
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Benazeprilat
Benazeprilat is a metabolite of benazepril. Benazepril, brand name Lotensin, is a medication used to treat high blood pressure, congestive heart failure, and chronic renal failure. Upon cleavage of its ester group by the liver, benazepril is converted into its active form benazeprilat, a non-sulfhydryl angiotensin-converting enzyme (ACE) inhibitor. (Wikipedia) D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
(10S,11R)-Pterosin C 4-glucoside
(10S,11R)-Pterosin C 4-glucoside is found in green vegetables. (10S,11R)-Pterosin C 4-glucoside is isolated from Pteridium aquilinum (bracken fern). Isolated from Pteridium aquilinum (bracken fern). (10S,11R)-Pterosin C 4-glucoside is found in green vegetables and root vegetables.
Pteroside P
Constituent of Pteridium aquilinum (bracken fern). Pteroside P is found in green vegetables and root vegetables. Pteroside P is found in green vegetables. Pteroside P is a constituent of Pteridium aquilinum (bracken fern).
4,5-Dihydroniveusin A
4,5-Dihydroniveusin A is found in fats and oils. 4,5-Dihydroniveusin A is a constituent of Helianthus annuus (sunflower). Constituent of Helianthus annuus (sunflower). 4,5-Dihydroniveusin A is found in sunflower and fats and oils.
fluticasone 17beta-carboxylic acid
fluticasone 17beta-carboxylic acid is a metabolite of fluticasone propionate. Fluticasone propionate is a corticosteroid derived from fluticasone used to treat asthma and allergic rhinitis (hay fever). It is also used to treat eosinophilic esophagitis. (Wikipedia)
Lobetyolin
2-(2-Amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine
Mocetinostat
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Lobetyolin
Unii-yjz71tro1X is a natural product found in Platycodon grandiflorus with data available. See also: Codonopsis pilosula root (part of). Lobetyolin, a bioactive compound, is derived from Codonopsis pilosula. Lobetyolin has anti-inflammatory, anti-oxidative and xanthine oxidase inhibiting activities. Lobetyolin also induces the apoptosis via the inhibition of ASCT2-mediated glutamine metabolism[1][2]. Lobetyolin is a click chemistry reagent, itcontains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Lobetyolin, a bioactive compound, is derived from Codonopsis pilosula. Lobetyolin has anti-inflammatory, anti-oxidative and xanthine oxidase inhibiting activities. Lobetyolin also induces the apoptosis via the inhibition of ASCT2-mediated glutamine metabolism[1][2]. Lobetyolin is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Lobetyolin, a bioactive compound, is derived from Codonopsis pilosula. Lobetyolin has anti-inflammatory, anti-oxidative and xanthine oxidase inhibiting activities. Lobetyolin also induces the apoptosis via the inhibition of ASCT2-mediated glutamine metabolism[1][2]. Lobetyolin is a click chemistry reagent, itcontains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
14,15β-dihydroxyklaineanone
14,15beta-Dihydroxyklaineanone is a natural product found in Eurycoma longifolia with data available.
4,5-Dihydroniveusin A
1-acetyl-11-methoxy-17,18-epoxy-cura-2(16),19-diene-12,17-diol|2,16-Dehydro-henningsolin
2alpha-hydroxy-8beta-2,3,5-trihydroxyangeloyloxycostunolide
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-14-hydroxy-19-methyl-, (21.alpha.,22.alpha.)-
methyl ester of 8alpha-(2-hydroxymethyl-2-butenoyloxy)-1beta,6alpha-dihydroxy-15-oxo-11(13)eudesmen-12-oic acid
10-(beta-D-glucopyranosyloxy)tetradeca-2,8-diene-4,6-diyne-1,14-diol|cordifolioidyne B
1alpha,10beta,15-trihydroxy-3-oxo-8beta-O-methylbutanoyl-4,11(13)-germacradien, 6alpha,12-olide
1beta-methoxy-3alpha-hydroxy-3,10beta-4,5alpha-diepoxy-8beta-isobutyroyloxy-germacra-11(13)-en-6alpha,12-olide
2alpha-isovaleryloxy-3,8-dioxo-11-peroxy-4beta,5beta,7,14-bis-epoxybisabol-9E-ene
methyl-11,12-methylenedioxy-N(1)-decarbomethoxy-chanofruticosinate
jerantinine C
An indole alkaloid that is jerantinine A substituted with an oxo group at position 13. Isolated from Tabernaemontana corymbosa, it exhibits cytotoxicity against human KB cells.
(2Z,8Z,12R)-tetradecadiene-4,6-diyne-1,12,14-triol-1-O-beta-D-glucopyranoside
yadanziolide T
A quassinoid that is picras-3-ene substituted by hydroxy groups at positions 1, 11, 12, 15 and 21 and oxo groups at positions 2 and 16. Isolated from the ethanol extract of the stem of Brucea mollis, it exhibits cytotoxic activity.
6beta,11alpha,16beta,17-tetrahydroxy-6,7-seco-6,20-epoxy-1alpha,7-olide-ent-kaur-15-one|jianshirubesin C
(1S,5R,8S,10R,11S,12S,13S)-5,8,11,12-diepoxy-10,13-dihydroxy-1-isopropenyl-8-methyl-3,6-dioxocyclotetradecan-12-carboxylate|gyrosanin A
3alpha,6beta,11beta,16beta-tetrahydroxy-6alpha,20-epoxy-6,7-seco-ent-kaur-15-one-1alpha,7-olide|sculponin P
2alpha,3alpha,10alpha,13alpha,16alpha,17-hexahydroxy-9alpha-methyl-15-oxo-20-nor-kauran-19-oic acid (19,10)-lactone|2??,3??,10??,13??,16??,17-Hexahydroxy-9??-methyl-15-oxo-20-nor-kauran-19-oic acid (19,10)-lactone
(6E,12E)-tetradecadiene-8,10-diyne-1,14-diol-3-O-beta-D-glucopyranoside
(16R)-2,5alpha-epoxy-12-methoxy-17-oxo-(2alpha)-1,2-dihydro-akuammilane-16-carboxylic acid methyl ester|12-methoxy-picralinal|Vincarinin|vincarinine
(19S)-17,19-epoxy-(20alphaH)-coryn-16-ene-5beta,16-dicarboxylic acid 16-methyl ester|19alpha-methyl-(20alpha)-18-oxa-yohimb-16-ene-5beta,16-dicarboxylic acid 16-methyl ester|5Alpha-Carboxytetrahydroalstonin
2(R),3(R)-pterosin L 3-O-alpha-L-arabinopyranoside
(1S,5S,6R,7R,8R,9S,10S,11R)-8,9-epoxy-1-hydroxy-2-oxo-5-angeloxyxanthan-6,12-olide
(-)-Fumaricine|(Z)-fumaridine|3-[(Z)-6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-ylmethylene]-6,7-dimethoxy-2,3-dihydro-isoindol-1-one|3-[(Z?)-6-(2-Dimethylamino-aethyl)-benzo[1,3]dioxol-5-ylmethylen]-6,7-dimethoxy-isoindolin-1-on|3-[(Z?)-6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-ylmethylene]-6,7-dimethoxy-isoindolin-1-one|3-[6-(2-Dimethylamino-aethyl)-benzo[1,3]dioxol-5-ylmethylen]-6,7-dimethoxy-isoindolin-1-on|3-[6-(2-dimethylamino-ethyl)-benzo[1,3]dioxol-5-ylmethylene]-6,7-dimethoxy-isoindolin-1-one|Fumaridine
2alpha,9alpha-dihydroxydivaricatolide-8-O-angelate
Tox21_303565
Quinine hydrochloride dihydrate (Qualaquin) is an orally active and can be used in anti-malarial studies. Quinine hydrochloride dihydrate is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].
14,15 β-Dihydroxyklaineanone
14,15beta-Dihydroxyklaineanone is a natural product found in Eurycoma longifolia with data available.
Quinine hydrochloride dihydrate
Quinine hydrochloride dihydrate (Qualaquin) is an orally active and can be used in anti-malarial studies. Quinine hydrochloride dihydrate is a potassium channel inhibitor that inhibits WT mouse Slo3 (KCa5.1) channel currents evoked by voltage pulses to +100?mV with an IC50 of 169 μM[1][2].
MLS002154212-01!Canrenoic acid potassium salt2181-04-6
2-[6-(3,4-dihydroxy-2-methylidenebutanoyl)oxy-4-ethenyl-2-hydroxy-3-(3-hydroxyprop-1-en-2-yl)-4-methylcyclohexyl]prop-2-enoic acid
(2S,3S,9R,12R,13R,14S,15R,16R,17S)-3,12,13,15,16-pentahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-5-ene-4,11-dione
(2S,3S,9R,12R,13R,14S,15R,16R,17S)-3,12,13,15,16-pentahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,?.0¹³,¹?]heptadec-5-ene-4,11-dione
benazeprilat
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Gly His Pro Ser
Gly His Ser Pro
Gly Pro His Ser
Gly Pro Ser His
Gly Ser His Pro
Gly Ser Pro His
His Gly Pro Ser
His Gly Ser Pro
His Pro Gly Ser
His Pro Ser Gly
His Ser Gly Pro
His Ser Pro Gly
Pro Gly His Ser
Pro Gly Ser His
Pro His Gly Ser
Pro His Ser Gly
Pro Ser Gly His
Pro Ser His Gly
Ser Gly His Pro
Ser Gly Pro His
Ser His Gly Pro
Ser His Pro Gly
Ser Pro Gly His
Ser Pro His Gly
10,11-epoxy-chlorovulone I
Pteroside P
(10S,11R)-Pterosin C 4-glucoside
10,11-epoxy-chlorovulone I
1,3-Phenylenebis(2,2-propanediyl-4,1-phenylene) dicyanate
Urea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-(2-chlorophenyl)-N-cyclohexyl- (9CI)
N,N-Bis[[4-(2-propen-1-yloxy)phenyl]methylene]-1,4-benzenediamine
7-Benzyloxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
Succinylcholine Chloride Dihydrate
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents
Methyl 4-(2-(3-((dimethylamino)Methyl) benzofuran-2-carboxamido)ethoxy)benzoate
Thiourea, N-[2-(1H-benzimidazol-2-yl)ethyl]-N-cyclohexyl-N-(4-fluorophenyl)- (9CI)
PF-04620110
PF-04620110 is a potent, selective and orally bioavailable diglyceride acyltransferase-1 (DGAT-1) inhibitor with an IC50 of 19 nM[1].
(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxylic acid
(6e,11e)-Heptadeca-6,11-Diene-9,9-Diylbis(Phosphonic Acid)
Mocetinostat
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Potassium canrenoate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
3,12,13,15,16-Pentahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.02,7.013,17]heptadec-5-ene-4,11-dione
2-[(4Z,12E)-1,7-dihydroxytetradeca-4,12-dien-8,10-diyn-6-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
4-Hydroxy-2-oxo-1-propyl-1,2-dihydro-quinoline-3-carboxylic acid 3,4-dimethoxy-benzylamide
2-(1-ethyl-4-oxo-3-furo[3,4]pyrrolo[3,5-c][1,2,4]triazinyl)-N-[4-(2-furanyl)butan-2-yl]propanamide
3-[2-[4-(4-fluorobenzoyl)piperidino]ethyl]quinazoline-2,4(1H,3H)-dione [R-(R*,R*)]-tartrate
N-[(2S)-1-(1H-benzimidazol-2-ylamino)-3-methyl-1-oxobutan-2-yl]-3,5-dimethoxybenzamide
N-[2-(cyclohexylamino)-1-(2-furanyl)-2-oxoethyl]-N-(2-furanylmethyl)-2-furancarboxamide
[5-[(4-Methoxy-1-naphthalenyl)oxymethyl]-3-isoxazolyl]-(4-methoxy-1-piperidinyl)methanone
3-(2-methylpropyl)-6-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]-1H-pyrimidine-2,4-dione
(2S)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-4-[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
2-[(2S,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
2-[(2S,3S,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
N-(2,3-dihydro-1H-inden-2-yl)-2-[(2R,5R,6R)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]acetamide
(2S)-2-[(4S,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4R,5R)-8-(3-methoxyprop-1-ynyl)-4-methyl-5-(methylaminomethyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
2-[(2R,3S,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,3S,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,3R,6S)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
2-[(2R,3R,6R)-3-[[anilino(oxo)methyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(2-pyridinylmethyl)acetamide
N-(2,3-dihydro-1H-inden-2-yl)-2-[(2S,5R,6S)-5-(ethylsulfonylamino)-6-(hydroxymethyl)-2-oxanyl]acetamide
(S)-[(2S,4S,5R)-5-Ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;dihydrate;hydrochloride
(2R,3R,4S,5S,6R)-2-[(4Z,6R,7R,12E)-1,6-dihydroxytetradeca-4,12-dien-8,10-diyn-7-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
(2S,3S,9R,12R,13R,14S,15R,16R,17S)-3,12,13,15,16-pentahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.02,7.013,17]heptadec-5-ene-4,11-dione
2-[6-(3,4-Dihydroxy-2-methylidenebutanoyl)oxy-4-ethenyl-2-hydroxy-3-(3-hydroxyprop-1-en-2-yl)-4-methylcyclohexyl]prop-2-enoic acid
2-(2-Amino-1H-benzo[d]imidazol-1-yl)-N-benzyl-8-methoxyquinazolin-4-amine
N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N5,N5-dimethyl-L-glutamine
N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N5,N5-dimethyl-L-glutamine is a glutamine derivative[1].
1-{9,14-dihydroxy-8-methoxy-15-oxa-1,11-diazahexacyclo[16.3.1.0⁴,¹².0⁴,²¹.0⁵,¹⁰.0¹³,¹⁹]docosa-5,7,9,12,17-pentaen-11-yl}ethanone
methyl 2-{13-formyl-8-methyl-12-oxo-11-oxa-8,16-diazapentacyclo[7.4.3.2¹⁰,¹³.0¹,⁹.0²,⁷]octadeca-2,4,6-trien-17-yl}but-2-enoate
(2r,3r,4s,5s,6r)-2-{[(2e,8z,12r)-12,14-dihydroxytetradeca-2,8-dien-4,6-diyn-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(2s)-5-(hydroxymethyl)-2,7-dimethyl-6-(2-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}ethyl)-2,3-dihydroinden-1-one
(1r,2s,3s,7s,9r,12r,13s,14s,15s,16r,17r)-3,12,14,15,16-pentahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-5-ene-4,11-dione
methyl 7-[1-chloro-4-hydroxy-4-(oct-2-en-1-yl)-2-oxo-6-oxabicyclo[3.1.0]hexan-3-ylidene]hept-5-enoate
(3s,6r)-3-({4-[(2r)-2,3-dihydroxy-3-methylbutoxy]phenyl}methyl)-1,4-dimethyl-6-(methylsulfanyl)piperazine-2,5-dione
3,12,13,15,16-pentahydroxy-2,6,14,17-tetramethyl-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-5-ene-4,11-dione
2,10,11-trihydroxy-2,6,11-trimethyl-7-oxo-8,14-dioxatetracyclo[8.4.0.0¹,¹³.0⁵,⁹]tetradecan-4-yl 2-methylbut-2-enoate
14β,15β-dihydroxyklaineanone
{"Ingredient_id": "HBIN001370","Ingredient_name": "14\u03b2,15\u03b2-dihydroxyklaineanone","Alias": "NA","Ingredient_formula": "C20H28O8","Ingredient_Smile": "CC1C(C(C2C3(C(CC4C2(C1(C(C(=O)O4)O)O)C)C(=CC(=O)C3O)C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5940","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s,3r)-pteroside c
{"Ingredient_id": "HBIN006685","Ingredient_name": "(2s,3r)-pteroside c","Alias": "NA","Ingredient_formula": "C20H28O8","Ingredient_Smile": "CC1C(C2=CC(=C(C(=C2C1=O)C)CCOC3C(C(C(C(O3)CO)O)O)O)C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18105","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2s,3s-pterosin c-3-o-β-d-glucoside
{"Ingredient_id": "HBIN006730","Ingredient_name": "2s,3s-pterosin c-3-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C20H28O8","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18128","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2S,3S)- pterosin C 3- O- β- glucopyranoside
{"Ingredient_id": "HBIN006731","Ingredient_name": "(2S,3S)- pterosin C 3- O- \u03b2- glucopyranoside","Alias": "NA","Ingredient_formula": "C20H28O8","Ingredient_Smile": "CC1C(C2=CC(=C(C(=C2C1=O)C)CCO)C)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41791","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}